Natalie Clayton's practice focuses on resolution of intellectual property disputes. She has extensive experience litigating intellectual property matters involving a wide range of legal issues. Natalie has represented clients in trials throughout the United States, and has particular expertise in Hatch-Waxman cases. She has been involved in patent cases covering diverse areas of technology, including pharmaceuticals, software, chemical, medical devices and mechanical devices. Natalie has represented clients in the pharmaceutical and gemological industries in trademark, false advertising and unfair competition cases brought under the Lanham Act. Natalie is also experienced in patent opinion practice, conducting due diligence investigations, reexamination proceedings and FDA regulatory matters involving pharmaceuticals and dietary ingredients.

Natalie is a member of the American and New York Bar Associations. She actively participates in several pro bono projects, including representing Sustainable Health Enterprises, a non-profit organization that seeks to bring market-based solutions to developing countries.